Spain The following infographic shows the main locations of the pharma sector in Spain, as well as the number of companies based in each region of the country.

The following chart shows the direct, indirect and induced employment by the pharma sector in Spain in 2013, a total of 200,000 people.

Spain The following ranking comes from April 2014, and provides a snapshot of the current top players in the Spanish pharma sector.

Spain Spain’s public expenditure on pharmaceuticals is today at the same level that it was in 1993 – the lowest in 20 years.

Portugal In terms of growth, the market began to show signs of improvement in 2012, overall market value has still not recovered from the recession, currently standing at around the same levels as 2002.

Poland Thanks to its strategic location, EU membership, and low cost base, Poland has successfully attracted investments from the global pharmaceutical industry. Today, over half of the top 30 pharma companies operating in Poland have manufacturing facilities or functional hubs (IT center, Clinical research, Shared Services, etc) in the country.

Poland Despite an overall growth slowdown in the Polish market, the OTC segment still offers many opportunities to pharma companies. Here are the top 10 OTC companies based on growth figure in 2013.

Although the Polpharma group takes first place in the 2013 rankings of pharmaceutical companies in Poland when measured by sales, it is the only domestic company to make it into the top ten, which is dominated by multinationals.  

Showing figures for September 2013, this table lists the top 20 pharma companies in the Portuguese market, based on sales.